...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter


All Biotech Press Releases



> AMSilk Founder Prof. Thomas Scheibel Receives DECHEMA Award
11/29/13
> PSR-Agility Orphan Drug Development Wins ROAR Award for “Best Orphan Drug CRO”
11/21/13
> Nanovi Secures Funding for BioXmark™ Injectable Tissue Liquid Marker in Radiotherapy
11/21/13
> Wheat, Barley and Maize Target Enrichment Designs for Exome Sequencing Available from Roche NimbleGen
11/20/13
> AMSilk Starts Worldwide Distribution of Spidersilk as Cosmetic Ingredient
11/20/13
> Biopharm GmbH Enters into Co-Research Agreement with Merck
11/20/13
> Anavex Reports Predicted Clinical Effect for ANAVEX 2-73 in Computer Simulation Model of Alzheimer’s Disease
11/18/13
> The NovAliX/Kyowa Hakko Kirin Alliance Will Commence a Fragment-Based Drug Discovery Project Targeting an Important Protein/Protein Interaction
11/18/13
> Ganymed Pharmaceuticals Closes EUR 45 Million Financing Round
11/18/13
> Selvita Announces Changes to Management Board
11/05/13
> Anavex Reports ANAVEX 2-73 Blocks Tau and Amyloid-Beta Proteins in a Preclinical Model of Alzheimer’s Disease
11/04/13
> MiRacle Consortium Led by InteRNA Technologies and VU University Medical Center Along with Quiet Therapeutics Receives a € 1.2 Million FP7 Grant from the European Union
11/04/13
> Canbex Therapeutics Commences Phase I Clinical Trial of Lead Product VSN16R as a Potential Treatment for Spasticity in Multiple Sclerosis
11/04/13
> TVM Capital to Focus on Life Science Venture and Healthcare Private Equity Investing Only
11/04/13
> Cancer Research Technology and Nuevolution Sign Multi-Target Deal to Seek Potential Cancer Drugs
11/04/13
> Completion of a “First in Human” Clinical Phase I Study with a Therapeutic Protein Derived from CAP® Cells
11/01/13
> ZoBio and Actelion Enter into Drug Discovery Collaboration
10/31/13
> ProBioGen Upholds Strong Patent Position in Viral Vaccine Manufacturing Field
10/30/13
> DSM Celebrates Opening of New cGMP Facility for Biopharmaceutical Manufacturing in Brisbane, Australia
10/30/13
> DSM and Opthea Sign Agreement to Manufacture Opthea’s Lead Product for Eye Disease
10/30/13
> Haselmeier Announces the CE Mark for JuniorSTAR® Half-Unit Insulin Pen
10/29/13
> Partnership Between AOP Orphan and Ferrer: Joint Marketing of Adasuve® in CEE
10/29/13
> DSM and Sanquin Sign Agreement for Commercial Manufacture of Factor IX - Antibody
10/24/13
> PharmaCell Announces Agreement to Be The European Contract Manufacturing Organization for Dendreon
10/23/13
> The Centre for Genomic Research at the University of Liverpool Certified to Provide Roche NimbleGen SeqCap EZ Services
10/22/13
> Ganymed’s IMAB362 Receives Orphan Drug Designation From FDA and EMA for Pancreatic Cancer
10/21/13
> Sartorius Stedim Biotech and BD Diagnostics Strengthen Cooperation in the Area of Microbiological Diagnostics
10/16/13
> AOP Orphan Pharmaceuticals Announces Progress of Pivotal Phase III Trial PROUD-PV of Novel Mono-Pegylated Interferon Alpha 2b for the Treatment of Polycythemia Vera
10/10/13
> S-TARget Achieves Clinical Proof of Concept for Allergy Vaccine SG100 in Asthmatic Non-human Primates
10/10/13
> Vetter to Construct New Filling Lines to Expand Capacity
10/09/13
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Page 5 of 32